Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Liese Vandeborne"'
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/8941062e3d0c457c90e7e3a8b54b3891
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-11 (2019)
Abstract Background Late and misdiagnoses of rare disease patients are common and often result in medical, physical and mental burden for the patient, and financial and emotional burden for the patient’s family. Low rare disease awareness among phy
Externí odkaz:
https://doaj.org/article/d471a78c41ca4a99973569d4a3ba5ef3
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Vaccines used to prevent infections have long been known to stimulate immune responses to cancer as illustrated by the approval of the Bacillus Calmette–Guérin (BCG) vaccine to treat bladder cancer since the 1970s. The recent approval of immunothe
Externí odkaz:
https://doaj.org/article/8c7f574ce33c4c72b9dad9844373ab58
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
A global, comprehensive and open access listing of approved anticancer drugs does not currently exist. Partial information is available from multiple sources, including regulatory authorities, national formularies and scientific agencies. Many such d
Externí odkaz:
https://doaj.org/article/86a2ecc5b4d547199735cd3630fa58de
Autor:
Gabry A.M. Kuijten, Nicolo Matteo Luca Battisti, Liese Vandeborne, Guy Buyens, Sergio Crispino
Publikováno v:
Journal of Clinical Oncology. 40:e13521-e13521
e13521 Background: The ACF is an independent private research foundation, based in Belgium and active internationally. Since its inception in 2013, patients and their relatives spontaneously contact the Fund to request information on treatment option
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f1327312cac433ca8850834b3fc9a1b
https://doi.org/10.1200/jco.2022.40.16_suppl.e13521
https://doi.org/10.1200/jco.2022.40.16_suppl.e13521
Autor:
Mahmoud Salama Ahmed, Martin K. Angele, Yasmeen M. Attia, João Basso, Gauthier Bouche, Sohini Chakraborti, Pushpaveni Chakravarthi, Hsuen-Wen Kate Chang, Vincent H.S. Chang, Bei Cheng, William C.S. Cho, Jan G. D'Haese, Q. Ping Dou, Thomas Efferth, Heba Ewida, Ana Fortuna, HemaSree GNS, Enrique Hernández-Lemus, Yingbo Huang, R. Stephanie Huang, Matthias Ilmer, Harras J. Khan, Mamatha Krishna Murthy, Stephan Kruger, Hansaim Lim, Swarna Mariam Jos, Lydie Meheus, Maria Mendes, Aritro Nath, Hanno Niess, Süreyya Ölgen, Zainab Sabry Othman Ahmed, Rachana R Pai, Alberto Pais, Pan Pantziarka, Siddhika Pareek, V Lakshmi PrasannaMarise, Bernhard W. Renz, Sagar O. Rohondia, Klara Rombauts, Ganesan Rajalekshmi Saraswathy, João Sousa, Narayanaswamy Srinivasan, Kenneth K.W. To, Liese Vandeborne, Rui Vitorino, Carla Vitorino, Maximilian Weniger, Jens Werner, C. Benedikt Westphalen, Yang Wu, Lei Xie, Peisheng Xu, Ge Yan, Nirav Zalavadiya, Chun Zhang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4aef2d9eab140cb243b6ecb192187a02
https://doi.org/10.1016/b978-0-12-819668-7.01002-2
https://doi.org/10.1016/b978-0-12-819668-7.01002-2
BackgroundThe global pandemic caused by SARS-CoV-2 virus has prompted an unprecedented international effort to seek medicines for prevention and treatment of infection. Drug repurposing has played a key part in this response. The rapid increase in tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73a0dc5c6e7982910ed783f80712c9a0
https://doi.org/10.1101/2020.05.27.20114371
https://doi.org/10.1101/2020.05.27.20114371
Repurposing is a drug development strategy that seeks new medical treatments using existing licensed drugs rather than from new molecular entities. There has been increasing interest in the use of this approach to develop innovative treatments in onc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b419fc99da0cf7b43acba0d39ba3db5
https://doi.org/10.1016/b978-0-12-819668-7.00001-4
https://doi.org/10.1016/b978-0-12-819668-7.00001-4
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-11 (2019)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases
Background Late and misdiagnoses of rare disease patients are common and often result in medical, physical and mental burden for the patient, and financial and emotional burden for the patient’s family. Low rare disease awareness among physicians i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fba1559d2c33f5d94c899883d1d8821f
https://lirias.kuleuven.be/handle/20.500.12942/703593
https://lirias.kuleuven.be/handle/20.500.12942/703593
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
e14564 Background: Vaccines used to prevent infection have long been known to stimulate immune responses to cancer as illustrated by the approval of the Bacillus Calmette–Guérin (BCG) vaccine to treat bladder cancer since the 1970s. The recent app
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::373299278bcd0fccb6ed935fb3166ac2
https://doi.org/10.1200/jco.2021.39.15_suppl.e14564
https://doi.org/10.1200/jco.2021.39.15_suppl.e14564